Hexamethylenebisacetamide Modulation of Thyroglobulin and Protein Levels in Thyroid Cells is not Mediated by Phosphatidylinositol-3-Kinase: A Study With Wortmannin

References

• Amphoux-Fazekas T, Depoortere F, Aouani A, Radulescu A, Hovsépian S, Coulonval K, Fayet G (1996): HMBA-induction of thyroid cell growth is associated with modi-fications of cdk2, cdk4 levels, intra- and extra-cellular protein patterns. J Endocrinol Invest 19 (suppl 6): 13.
   Google Scholar
• Amphoux-Fazekas T, Fayet G, Hovsépian S, Aouani A, Samih N (1997): L'hexaméthylène bisacétamide (HMBA) supprime la perte de sensibilité des cellules thyrokliennes monocouche de pore a la thyrotropine. C. R. Acad. Sci. Paris, Life Sciences 320: 1–11.
   Google Scholar
• Aouani A, Hovsépian S, Fayet G (1987): cAMP dependent and independent regulation of thyroglobulin synthesis by two clones of the OVNIS 6H thyroid cell line. Mol Cell Endocrinol 52: 151–160..
   PubMed Web of Science ®Google Scholar
• Aouani A, Samih N, Amphoux-Fazekas T, Mezghrani A, Mykhaylov S, Hovsépian S, Lombardo D, Fayet G (1999): HMBA increases thyroglobulin levels in porcine thyroid cells without increasing cAMP. Horm Metab Res (in press).
   Google Scholar
• Carpenter CL, Cantley LC (1996): Phosphoinositide 3-kinase and the regulation of cell growth. Biochim Biophys Acta 1288: M11—M16.
   PubMed Web of Science ®Google Scholar
• Dardevet D, Sornet C, Vary T, Grizard J (1996): Phos-phatidylinositol 3-kinase and p70s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and Insulin Growth Factor I. Endocrinology 137: 4087–4094.
   PubMed Web of Science ®Google Scholar
• Dremier S, Taton M. Coulonval K, Nakamura T, Matsumoto K, Dumont JE (1994): Mitogenic, dedifferentiating and scattering effects hepatocyte growth factor on dog thyroid cells. Endocrinology 135: 135–140.
   PubMed Web of Science ®Google Scholar
• Eccles N, Ivan M, Wynford Thomas D (1996): Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by growth factor. Mol Cell Endocrinol 117: 247–251.
   Google Scholar
• Fayet G, Hovsépian S (1977): Active transport of iodide in isolated porcine thyroid cells-Appplication to an in vitro bioassay of thyrotropin. Mol Cell Endocrinol 7: 67–78.
   PubMed Web of Science ®Google Scholar
• Fayet G, Hovsépian S, Dickson JG, Lissitzky S (1982): Reorganization of porcine thyroid cells into functional fol-licle in a chemically defined, serum and thyrotropin-free medium. J Cell Biol 93: 479–488.
   PubMed Web of Science ®Google Scholar
• Fayet G, Hovsépian S (1985): Strategy of thyroid cell culture in defined media and the isolation of the OVNIS and PORTHOS cell strains. Thyroglobulin: The prothyroid hormone, progress in endocrine research and therapy, Raven Press, New York 2: 211–224.
   Google Scholar
• Fayet G, Amphoux-Fazekas T, Aouani A, Hovsépian S (1996): Hexamethylenebisacetamide (HMBA) is a growth factor for human, ovine and porcine thyroid cells. Mol Cell Endocrinol 117: 111–116.
   PubMed Web of Science ®Google Scholar
• Fibach E, Reuben RC, Rifkind RA, Marks PA (1977): Effect of Hexamethylenebisacetamide on the commitment to ter-minal differentiation of murine erythroleukemia cells. Cancer Res 37: 440–444.
   PubMed Web of Science ®Google Scholar
• Hansen SH, Olsson A, Casanova JE (1995): Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcyto-sis in polarized epithelial cells. J Biol Chem 270: 28425–28432.
   PubMed Web of Science ®Google Scholar
• Lee AD, Hansen PA Holloszy JO (1995): Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett 361: 51–54.
   PubMed Web of Science ®Google Scholar
• LeMarchand-Brustel Y, Gautier N, Cormont M, Van Obberghen E (1995): Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: comparison with fat cells. Endocrinology 136: 3564–3570.
   PubMed Web of Science ®Google Scholar
• Marks PA, Breslin R, Rifkind RA, Ngo L, Singh R (1989): Polar/apolar chemical inducers of differentiation of trans-formed cells: strategies to improve therapeutic potential. Proc Natl Acad Sci USA 86: 6358–6362.
   PubMed Web of Science ®Google Scholar
• Martin SS, Rose DW, Saltiel AR. Klippel A, Williams LT, Olefsky JM (1996): Phosphatidylinositol 3-kinase is nec-essary and sufficient for insulin-stimulated stress fiber breakdown. Endocrinology 137: 5045–5054.
   PubMed Web of Science ®Google Scholar
• Melloni E, Pontremoli S, Viotti PL. Patrone M, Marks PA, Rifkind RA (1989): Differencial expression of proteine kinase C isozymes and erythroleukemia differentiation. J Biol Chem 264: 18414–18418.
   PubMed Web of Science ®Google Scholar
• Michaeli J, Busquets X, Orlow I, Younes A, Colomer D, Marks PA, Rifkind RA, Kolesnick RA (1992): A rise and fall in 1,2-Diacylglycerol content signal Hexamethyl-enebisacetamide-induced erythropoeisis. J Biol Chem 267: 23463–23466.
   PubMedGoogle Scholar
• Minamide LS, Bambourg JR (1990): A filter paper dye-bind-ing assay for quantitative determination of protein with-out interference from reducing agents or detergents. Biochemistry 190: 66–70.
   Web of Science ®Google Scholar
• Nakamura I, Takahashi N, Sasaki T, Tanaka S, Udagawa N, Murakami H, Kimura K, Kabuyama Y, Kurokawa T, Suda T, Fukui Y (1995): Wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase, blocks osteoclastic bone resorption. FEBS Lett 361: 79–84.
   PubMed Web of Science ®Google Scholar
• Okada T, Kawano Y, Sakakibara T, Hazeki 0, Ui M (1994): Essential role of phosphatidylinosito1-3 kinase in insulin induced glucose transport and lipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 269: 3568–3573.
   Google Scholar
• Roche S, Koegi M, Courtneidge SA (1994): The phos-phatidylinosito1-3-Kinase is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci USA 91: 9185–9189.
   PubMed Web of Science ®Google Scholar
• Roger PP, Dumont JE (1984): Factors controlling prolifera-tion and differentiation of canine thyroid cells cultured in reduced serum conditions: effects of thyrotropin, cyclic AMP and growth factors. Mol Cell Endocrinol 36: 79–93.
   PubMed Web of Science ®Google Scholar
• Saito Y, Mori S, Yokote K, Kanzaki T, Saito Y, Morisaki N (1996): Phophatidylinositol 3-kinase activity is required for the activation process of focal adhesion kinase by platelet-derived growth factor. Biochem Biophys Res Comm 224: 23–26.
   Google Scholar
• Shimizu Y, Shimizu T (1994): Effects of Wortmannin on increased glucose transport by insulin and Norepinephrine in primary culture of brown adipocytes. Biochem Biophys Res Comm 202: 660–665.
   PubMed Web of Science ®Google Scholar
• Skouteris GG, Georgakopoulos E (1996): Hepatocyte growth factor-induced proliferation of primary hepatocytes is mediated by activation of Phophatidylinositol 3-kinase. Biochem Biophys Res Comm 218: 229–233.
   PubMed Web of Science ®Google Scholar
• Straub SG, Sharp GWG (1996): A Wortmannin-sensitive sig-nal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide. J Biol Chem 271: 1660–1668.
   PubMed Web of Science ®Google Scholar
• Uribe JM, Keely SJ. Traynor-Kaplan AE, Barrett KE (1996): Phophatidylinositol 3-kinase mediates the inhibitory effect of epidermal growth factor on calcium-dependent chloride secretion. J Biol Chem 271: 26588–26595.
   PubMed Web of Science ®Google Scholar